paclitaxel has been researched along with Parkinson Disease, Secondary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akaike, A; Hongo, H; Izumi, Y; Kihara, T; Kume, T; Niidome, T; Sugimoto, H | 1 |
| Aminoff, MJ; Boban, D; Brandt, R; Brühmann, J; Cabin, DE; Christine, CW; Epling, L; Fanara, P; Hellerstein, MK; Husted, KH; Killian, M; Killion, S; Kohlstaedt, LA; Liu, S; Liu, VM; Nussbaum, RL; Peterson, J; Price, RW; Protasio, JC; Riiff, T; Sinclair, E; Wong, PY | 1 |
2 other study(ies) available for paclitaxel and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Glycogen synthase kinase-3β activation mediates rotenone-induced cytotoxicity with the involvement of microtubule destabilization.
Topics: Cell Line, Tumor; Electron Transport Complex I; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Maleimides; Microtubules; Paclitaxel; Parkinson Disease, Secondary; Phosphorylation; Reactive Oxygen Species; Rotenone; tau Proteins; Tubulin Modulators | 2012 |
Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Amyloid beta-Protein Precursor; Animals; Axonal Transport; Biomarkers; Case-Control Studies; Chromogranin B; Female; Humans; Kinetics; Male; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Microtubules; Mutation, Missense; Neuregulin-1; Nocodazole; Noscapine; Paclitaxel; Parkinson Disease, Secondary; Superoxide Dismutase; Superoxide Dismutase-1; tau Proteins; Tubulin Modulators | 2012 |